Cargando…

Prevention of Sudden Death in Hypertrophic Cardiomyopathy

Detalles Bibliográficos
Autores principales:	Arteaga-Fernández, Edmundo, Antunes, Murillo de Oliveira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia - SBC 2018
Materias:	Short Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023624/ https://www.ncbi.nlm.nih.gov/pubmed/30226911 http://dx.doi.org/10.5935/abc.20180101

Ejemplares similares

Differing strategies for sudden death prevention in hypertrophic cardiomyopathy
por: Maron, Martin S, et al.
Publicado: (2023)

The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death
por: Freitas, Pedro, et al.
Publicado: (2019)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Risk factors of sudden cardiac death in hypertrophic cardiomyopathy
por: Hong, Ying, et al.
Publicado: (2022)

Defying the Odds of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
por: Rostomian, Ara H., et al.
Publicado: (2020)

Cheyne‐stokes respiration associated with hypertrophic cardiomyopathy and normal left ventricular ejection fraction
por: Pedrosa, Rodrigo P, et al.
Publicado: (2010)

Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: What has Changed in The Guidelines?
por: Reis, Liliana, et al.
Publicado: (2018)

Lack of reliable clinical predictors to identify obstructive sleep apnea in patients with hypertrophic cardiomyopathy
por: Nerbass, Flávia B., et al.
Publicado: (2013)

Hypertrophic cardiomyopathy: Sudden cardiac death risk stratification in adults
por: Jordà, Paloma, et al.
Publicado: (2018)

Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity
por: Bonaventura, Jiri, et al.
Publicado: (2023)

Electrocardiographic amplitudes: a new risk factor for sudden death in hypertrophic cardiomyopathy
por: Östman-Smith, Ingegerd, et al.
Publicado: (2010)

Myocardial Fibrosis in Hypertrophic Cardiomyopathy: What Remains to be Proven?
por: Sara, Leonardo
Publicado: (2019)

Septal Ablation in Obstructive Hypertrophic Cardiomyopathy (oHCM)
por: Almeida, Dirceu Rodrigues
Publicado: (2019)

Clinical predictors of a positive genetic test in hypertrophic cardiomyopathy in the Brazilian population
por: Marsiglia, Julia Daher Carneiro, et al.
Publicado: (2014)

Rare association of left ventricular non-compaction and hypertrophic cardiomyopathy
por: Hotta, Viviane Tiemi, et al.
Publicado: (2020)

Ventricular arrhythmia and sudden cardiac death in hypertrophic cardiomyopathy: From bench to bedside
por: Shen, Hua, et al.
Publicado: (2022)

The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2021)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Prevention of Sudden Cardiac Death
por: Francis, Johnson
Publicado: (2011)

Hypertrophic Cardiomyopathy Mimicking Acute Anterior Myocardial Infarction Associated with Sudden Cardiac Death
por: Daralammouri, Y., et al.
Publicado: (2012)

Predictors of risk for sudden death in childhood hypertrophic cardiomyopathy: the importance of the ECG risk score
por: Östman-Smith, Ingegerd, et al.
Publicado: (2017)

A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy
por: Miron, Anastasia, et al.
Publicado: (2020)

Novel FHL1 Mutation Associated With Hypertrophic Cardiomyopathy, Sudden Cardiac Death, and Myopathy
por: Binder, M. Scott, et al.
Publicado: (2020)

What Aspects of Phenotype Determine Risk for Sudden Cardiac Death in Pediatric Hypertrophic Cardiomyopathy?
por: Östman-Smith, Ingegerd
Publicado: (2022)

High T2-weighted signal intensity for risk prediction of sudden cardiac death in hypertrophic cardiomyopathy
por: Gommans, D. H. Frank, et al.
Publicado: (2017)

Sudden cardiac death risk in hypertrophic cardiomyopathy: comparison between echocardiography and magnetic resonance imaging
por: Śpiewak, Mateusz, et al.
Publicado: (2021)

Updated risk assessments for sudden cardiac death in hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator
por: Park, Yae Min
Publicado: (2023)

Solving the Riddle of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: The Added Role of Cardiac Magnetic Resonance
por: Stankowski, Kamil, et al.
Publicado: (2023)

Rest perfusion abnormalities in hypertrophic cardiomyopathy: correlation with myocardial fibrosis and risk factors for sudden cardiac death
por: Chiribiri, A., et al.
Publicado: (2015)

Description of a New GLA Gene Variant in a Patient with Hypertrophic Cardiomyopathy. Is it Fabry Disease?
por: Bittencourt, Marcelo Imbroinise
Publicado: (2019)

Utility of T-wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy
por: Sugrue, Alan, et al.
Publicado: (2017)

Electrical storm in hypertrophic cardiomyopathy: Cardiac magnetic resonance and sudden cardiac death risk stratification: a case report
por: Garcia Brás, Pedro, et al.
Publicado: (2023)

Risk stratification in hypertrophic cardiomyopathy
por: Desai, Milind, et al.
Publicado: (2019)

Late gadolinium enhancement is compatible with advanced age in hypertrophic cardiomyopathy: implications for risk stratification of sudden death
por: Chan, Raymond H, et al.
Publicado: (2012)

Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy
por: Ismail, Tevfik F, et al.
Publicado: (2013)

Synchronous cardiac arrest in monozygotic twins with hypertrophic cardiomyopathy - Is sudden cardiac death genetically pre-programmed?
por: Goh, Cheng Yee, et al.
Publicado: (2015)

Conversion of left atrial volume to diameter for automated estimation of sudden cardiac death risk in hypertrophic cardiomyopathy
por: Bhopalwala, Huzefa, et al.
Publicado: (2020)

Validation of the 2020 AHA/ACC Risk Stratification for Sudden Cardiac Death in Chinese Patients With Hypertrophic Cardiomyopathy
por: Dong, Yan, et al.
Publicado: (2021)

Radiomics Analysis Derived From LGE-MRI Predict Sudden Cardiac Death in Participants With Hypertrophic Cardiomyopathy
por: Wang, Jie, et al.
Publicado: (2021)

External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6tcsngjnc81trud739i4ur48qn